Tibet Duo Rui Pharmaceutical Co (SZSE:301075) 3-Year EBITDA Growth Rate : -38.20% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Tibet Duo Rui Pharmaceutical Co 3-Year EBITDA Growth Rate?

Tibet Duo Rui Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥-0.03.

During the past 12 months, Tibet Duo Rui Pharmaceutical Co's average EBITDA Per Share Growth Rate was 126.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -38.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -42.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Tibet Duo Rui Pharmaceutical Co was -38.20% per year. The lowest was -46.30% per year. And the median was -43.20% per year.

Competitive Comparison of Tibet Duo Rui Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Duo Rui Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tibet Duo Rui Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tibet Duo Rui Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Tibet Duo Rui Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Tibet Duo Rui Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Tibet Duo Rui Pharmaceutical Co (SZSE:301075) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Tibet Duo Rui Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Tibet Duo Rui Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Duo Rui Pharmaceutical Co (SZSE:301075) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Duo Rui Pharmaceutical Co Ltd (SZSE:301075) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Biomedical Park, Area A, 3rd Floor, Building 1, Changdu Economic Development Zone, Tibet Autonomous Region, Tibet, CHN, 854000

Website

http://www.duoruiyy.com

Duo Rui Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical pharmaceutical preparations and their raw materials.

Tibet Duo Rui Pharmaceutical Co (SZSE:301075) Headlines

No Headlines